Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

West Pharmaceutical Servs Raises FY2025 GAAP EPS Guidance from $6.36-$6.56 to $6.75-$6.80 vs $6.53 Est

Author: Benzinga Newsdesk | October 23, 2025 05:01am
West Pharmaceutical Servs (NYSE:WST) raises FY2025 GAAP EPS guidance from $6.36-$6.56 to $6.75-$6.80 vs $6.53 analyst estimate..

Posted In: WST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist